Get startedLog in
    Picture of Englewood Lab logo

    950140 — Englewood Lab Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Englewood Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue141117158134152
    Cost of Revenue
    Gross Profit30.12036.628.342.2
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses126110136120126
    Operating Profit14.87.6522.113.826.3
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes13.26.472218.925.1
    Provision for Income Taxes
    Net Income After Taxes13.15.6215.914.417.4
    Net Income Before Extraordinary Items
    Net Income13.15.6215.914.417.4
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income13.15.6215.914.417.4
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.7340.3130.7910.7240.877
    Dividends per Share